Bullous Pemphigoid Associated with Squamous Cell Lung Carcinoma Showing Remarkable Response to Carboplatin-based Chemotherapy: a Case Report

Overview

Journal J Med Case Rep

Publisher Biomed Central

Specialty General Medicine

Date 2022 May 5

PMID 35513831

Authors

Prajwol Shrestha

Mathew K George

Sweta Baidya

Sunil K Rai

Affiliations

Soon will be listed here.

Abstract

Background: Bullous pemphigoid is an uncommon dermatologic manifestation seen in squamous cell lung cancer, and evidence guiding optimal treatment, especially in the elderly population, is limited. We report herein a case of squamous cell lung cancer diagnosed after being investigated for refractory bullous pemphigoid showing marked response to carboplatin-based chemotherapy. This is the first case report that shows carboplatin can be used as an effective alternative in treatment of malignancy-associated bullous pemphigoid.

Case Report: An 80-year-old caucasian man developed extensive vesiculobullous rashes on his trunk, chest, abdomen, and inguinal region associated with significant pruritus causing sleep disturbance. The diagnosis of bullous pemphigoid was confirmed on skin biopsy. The skin lesions continued to worsen even after use of oral and topical steroid in addition to oral doxycycline. Chest computed tomography revealed a spiculated left lung lesion along with mediastinal lymphadenopathy. Fine-needle aspiration from the mediastinal lymph node confirmed metastatic squamous cell lung carcinoma. Carboplatin with gemcitabine was initiated, and significant response was seen within 3 days of chemotherapy. The skin lesions continued to remain in remission even after stopping the chemotherapy.

Conclusion: Although there are still controversies regarding paraneoplastic etiology of bullous pemphigoid, this case presents a temporal association. It is the first case report showing a remarkable response with the use of a carboplatin-based regimen.

Citing Articles

Resolution of Bullous Pemphigoid Following Lung Cancer Resection: A Case of Paraneoplastic Pemphigoid.

Youh J, Mizukami T, Nagata Y, Ito K Cureus. 2024; 16(11):e73485.

PMID: 39669836 PMC: 11635038. DOI: 10.7759/cureus.73485.

Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid.

Baum S, Steinberg S, Tzanani I, Barzilai A, Lyakhovitsky A Acta Derm Venereol. 2023; 103:adv00888.

PMID: 36916952 PMC: 10026015. DOI: 10.2340/actadv.v103.3979.

References

Janah H, Mahhou M, Souhi H, Zegmout A, Naji-Amrani H, Raoufi M . [Bullous pemphigoid revealing bronchial carcinoma]. Pan Afr Med J. 2015; 19:45. PMC: 4317072. DOI: 10.11604/pamj.2014.19.45.5160. View

Robak E, Robak T . Skin lesions in chronic lymphocytic leukemia. Leuk Lymphoma. 2007; 48(5):855-65. DOI: 10.1080/10428190601137336. View

Forsti A, Jokelainen J, Timonen M, Tasanen K . Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital. Br J Dermatol. 2014; 171(5):1223-6. DOI: 10.1111/bjd.13189. View

Graham-Brown R . Bullous pemphigoid with figurate erythema associated with carcinoma of the bronchus. Br J Dermatol. 1987; 117(3):385-8. DOI: 10.1111/j.1365-2133.1987.tb04147.x. View

Safini F, Tawfiq N . [Paraneoplastic bullous pemphigoid associated with lung cancer]. Pan Afr Med J. 2015; 21:248. PMC: 4607980. DOI: 10.11604/pamj.2015.21.248.6034. View

Ogawa H, Sakuma M, Morioka S, Kitamura K, Sasai Y, Imamura S . The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. J Dermatol Sci. 1995; 9(2):136-41. DOI: 10.1016/0923-1811(94)00371-k. View

ROOK A . A pemphigoid eruption associated with carcinoma of the bronchus. Trans St Johns Hosp Dermatol Soc. 1968; 54(2):152-4. View

Lakhdar N, El Khattabi W, Lahroussi M, Afif H, Aichane A . [Small cell lung cancer associated with paraneoplastic bullous pemphigoid]. Rev Pneumol Clin. 2014; 70(3):169-72. DOI: 10.1016/j.pneumo.2013.11.011. View

Balestri R, Magnano M, La Placa M, Patrizi A, Angileri L, Tengattini V . Malignancies in bullous pemphigoid: A controversial association. J Dermatol. 2015; 43(2):125-33. DOI: 10.1111/1346-8138.13079. View

10.

Joly P, Baricault S, Sparsa A, Bernard P, Bedane C, Duvert-Lehembre S . Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol. 2012; 132(8):1998-2004. DOI: 10.1038/jid.2012.35. View

11.

Shigemori M, Yoshida S, Azai S, Fujii K, Azuma K, Nishikawa H . [An autopsied case of G-CSF producing lung cancer with bullous pemphigoid and hyper gammaglobulinemia]. Nihon Naika Gakkai Zasshi. 2002; 90(10):2066-8. DOI: 10.2169/naika.90.2066. View

12.

Chung V, Moschella S, Zembowicz A, Liu V . Clinical and pathologic findings of paraneoplastic dermatoses. J Am Acad Dermatol. 2006; 54(5):745-62. DOI: 10.1016/j.jaad.2004.06.051. View

13.

Lindelof B, Islam N, Eklund G, Arfors L . Pemphigoid and cancer. Arch Dermatol. 1990; 126(1):66-8. DOI: 10.1001/archderm.1990.01670250072011. View

14.

Chang Y, Liu H, Wong C . Bullous pemphigoid--a report of 86 cases from Taiwan. Clin Exp Dermatol. 1996; 21(1):20-2. View

15.

Cakmak O, Seckin D, Ceken I, Yilmaz I, Akkuzu B, Ozluoglu L . Bullous pemphigoid associated with parotid carcinoma. Otolaryngol Head Neck Surg. 2002; 127(4):354-6. DOI: 10.1067/mhn.2002.128603. View

16.

Das A, Das S, Das S, Basuthakur S . A case of paraneoplastic bullous pemphigoid in association with squamous cell carcinoma of lung. J Postgrad Med. 2015; 61(3):197-9. PMC: 4943416. DOI: 10.4103/0022-3859.150906. View

17.

Stone S, Schroeter A . Bullous pemphigoid and associated malignant neoplasms. Arch Dermatol. 1975; 111(8):991-4. View

18.

Pelosof L, Gerber D . Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2010; 85(9):838-54. PMC: 2931619. DOI: 10.4065/mcp.2010.0099. View

19.

Takeuchi M, Okazaki A, Nakajima N, Saito Y, Nozaki M, NIIBE H . [A case of lung cancer with bullous pemphigoid]. Gan No Rinsho. 1986; 32(5):529-33. View

20.

Robinson N, Hashimoto T, Amagai M, Chan L . The new pemphigus variants. J Am Acad Dermatol. 1999; 40(5 Pt 1):649-71; quiz 672-3. DOI: 10.1016/s0190-9622(99)70145-3. View